Newport Biopharmaceutical Technology

Newport Biopharmaceutical Technology is a biotechnology company focused on the development of innovative biologics and providing high-end contract development and manufacturing services. The company specializes in the discovery and optimization of therapeutic antibodies, including monoclonal and bispecific formats, primarily targeting oncology and autoimmune indications. Newport Biopharmaceutical leverages advanced high-throughput screening and cell line development platforms to accelerate the transition of drug candidates from discovery to clinical manufacturing. Their business model integrates internal drug discovery programs with strategic CDMO partnerships to support the global biopharmaceutical industry.